SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-024253
Filing Date
2022-10-17
Accepted
2022-10-17 17:30:41
Documents
18
Period of Report
2022-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20221017_8k.htm   iXBRL 8-K 38902
2 EXHIBIT 10.1 ex_432818.htm EX-10.1 40591
7 ex_432818img006.jpg GRAPHIC 3262
8 ex_432818img007.jpg GRAPHIC 2656
9 ex_432818img008.jpg GRAPHIC 2882
10 logo01.jpg GRAPHIC 9028
  Complete submission text file 0001437749-22-024253.txt   248845

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA stab-20221011.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20221011_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20221011_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20221011_pre.xml EX-101.PRE 11689
12 EXTRACTED XBRL INSTANCE DOCUMENT cbli20221017_8k_htm.xml XML 2567
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 221314426
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences